.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The 10-year SLEEVEPASS randomized clinical trial provides unusually long follow-up comparing laparoscopic sleeve gastrectomy with Roux-en-Y gastric bypass in patients with obesity. Both procedures produced durable weight loss and meaningful improvement in obesity-related comorbidities, but the long-term profiles were not identical. Gastric bypass generally offered greater weight reduction and better reflux outcomes, while sleeve gastrectomy remained an effective operation with its own technical advantages. The study is particularly important for preoperative counseling because many differences between bariatric procedures emerge over years rather than during the initial postoperative period. Long-term reflux, weight trajectory, metabolic disease and the possibility of revisional surgery should therefore be discussed before selecting an operation. For bariatric teams, the trial also illustrates why outcome assessment should extend beyond percentage weight loss: the best procedure is the one that offers an acceptable balance of efficacy, adverse effects, technical considerations and patient preferences. Ten-year randomized evidence strengthens shared decision-making between surgeon and patient.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The 10-year SLEEVEPASS randomized clinical trial provides unusually long follow-up comparing laparoscopic sleeve gastrectomy with Roux-en-Y gastric bypass in patients with obesity. Both procedures produced durable weight loss and meaningful improvement in obesity-related comorbidities, but the long-term profiles were not identical. Gastric bypass generally offered greater weight reduction and better reflux outcomes, while sleeve gastrectomy remained an effective operation with its own technical advantages. The study is particularly important for preoperative counseling because many differences between bariatric procedures emerge over years rather than during the initial postoperative period. Long-term reflux, weight trajectory, metabolic disease and the possibility of revisional surgery should therefore be discussed before selecting an operation. For bariatric teams, the trial also illustrates why outcome assessment should extend beyond percentage weight loss: the best procedure is the one that offers an acceptable balance of efficacy, adverse effects, technical considerations and patient preferences. Ten-year randomized evidence strengthens shared decision-making between surgeon and patient.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
Yesterday
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
2 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
2 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
2 days back
